Clearside Biomedical, Inc. vs Oculis
Clearside Biomedical, Inc.
Revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®)
39 employees · est. 2012
Clearside Biomedical, Inc. is the older company (2012 vs 2017); Oculis is the larger of the two.
Side-by-Side Comparison
| Metric | Clearside Biomedical, Inc. | Oculis |
|---|---|---|
| Founded | ||
| Founded | 2012 older | 2017 |
| Headquarters | ||
| Headquarters | Not tracked yet | Lausanne, Switzerland |
| Employees | ||
| Employees | 39 | 77 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $203.90M | $345.73M |
| Funding Rounds | ||
| Funding Rounds | 8 | 13 |
| Services | ||
| Services | Not tracked yet | Development of ophthalmic and neuro-ophthalmic treatments, Innovative pipeline and clinical trials, Transformative patient-centric solutions |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with diabetic macular edema, Patients with dry eye disease, Patients with optic neuritis, Medical professionals in ophthalmology and neuro-ophthalmology |
| Taxonomy | ||
| Taxonomy | Ophthalmic CompanyBiopharmaceuticalOcular Microinjection PlatformRetinal DiseaseUveitisDiabetic Macular Edema +10 | Biopharmaceutical CompanyOphthalmic DiseasesDrug Delivery PlatformDiabetic Macular EdemaCataract Surgery InflammationDry Eye Disease +9 |
| Website | ||
| Website | clearsidebio.com | oculis.com |
About Clearside Biomedical, Inc.
Clearside Biomedical, Inc. is a biopharmaceutical company that is revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). The company's proprietary SCS Microinjector® enables a non-surgical procedure for the targeted and compartmentalized delivery of...
About Oculis
Oculis, founded in 2017, is a global biopharmaceutical company, publicly listed as Nasdaq: OCS and XICE: OCS. With headquarters in Switzerland and operations in the U.S. and Iceland, the company is focused on saving sight and enhancing eye care worldwide. Its innovative pipeline features multiple...
Also comparing in this category
Comparing more than these two?
Get Clearside Biomedical, Inc., Oculis and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Clearside Biomedical, Inc. compare?
A PDF of Clearside Biomedical, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Clearside Biomedical, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Clearside Biomedical, Inc. on 12 Sep 2024, and Oculis on 6 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
